Statistics for Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
Total visits
| views | |
|---|---|
| Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study | 2 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 1 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:cb85aaf8-5de0-4f23-966d-66bfd5569d0f | 17 |
| java.util.UUID:d5ec1ff2-d2fc-4ba9-a5a5-0f417a507ef3 | 10 |
| java.util.UUID:c404213b-33bd-43db-a776-dbded899adf8 | 9 |
Top country views
| views | |
|---|---|
| United States | 1 |
Top city views
| views | |
|---|---|
| Franklin | 1 |